Segui
Enrico Longato
Enrico Longato
Department of Information Engineering, University of Padova
Email verificata su dei.unipd.it
Titolo
Citata da
Citata da
Anno
Prevalence and impact of diabetes among people infected with SARS-CoV-2
GP Fadini, ML Morieri, E Longato, A Avogaro
Journal of endocrinological investigation 43 (6), 867-869, 2020
4472020
Exposure to dipeptidyl‐peptidase‐4 inhibitors and COVID‐19 among people with type 2 diabetes: A case‐control study
GP Fadini, ML Morieri, E Longato, BM Bonora, S Pinelli, E Selmin, ...
Diabetes, Obesity and Metabolism 22 (10), 1946-1950, 2020
882020
Cardiovascular outcomes of type 2 diabetic patients treated with SGLT-2 inhibitors versus GLP-1 receptor agonists in real-life
E Longato, B Di Camillo, G Sparacino, L Gubian, A Avogaro, GP Fadini
BMJ Open Diabetes Research and Care 8 (1), e001451, 2020
372020
Diabetes diagnosis from administrative claims and estimation of the true prevalence of diabetes among 4.2 million individuals of the Veneto region (North East Italy)
E Longato, B Di Camillo, G Sparacino, C Saccavini, A Avogaro, GP Fadini
Nutrition, Metabolism and Cardiovascular Diseases 30 (1), 84-91, 2020
362020
A practical perspective on the concordance index for the evaluation and selection of prognostic time-to-event models
E Longato, M Vettoretti, B Di Camillo
Journal of Biomedical Informatics 108, 103496, 2020
292020
Better cardiovascular outcomes of type 2 diabetic patients treated with GLP-1 receptor agonists versus DPP-4 inhibitors in clinical practice
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
Cardiovascular diabetology 19 (1), 1-12, 2020
222020
HAPT2D: high accuracy of prediction of T2D with a model combining basic and advanced data depending on availability
B Di Camillo, L Hakaste, F Sambo, R Gabriel, J Kravic, B Isomaa, ...
European journal of endocrinology 178 (4), 331-341, 2018
132018
Simple linear support vector machine classifier can distinguish impaired glucose tolerance versus type 2 diabetes using a reduced set of CGM-based glycemic variability indices
E Longato, G Acciaroli, A Facchinetti, A Maran, G Sparacino
Journal of diabetes science and technology 14 (2), 297-302, 2020
122020
Glycaemic variability-based classification of impaired glucose tolerance vs. type 2 diabetes using continuous glucose monitoring data
E Longato, G Acciaroli, A Facchinetti, L Hakaste, T Tuomi, A Maran, ...
Computers in biology and medicine 96, 141-146, 2018
112018
A deep learning approach to predict diabetes’ cardiovascular complications from administrative claims
E Longato, GP Fadini, G Sparacino, A Avogaro, L Tramontan, ...
IEEE Journal of Biomedical and Health Informatics 25 (9), 3608-3617, 2021
82021
Cardiovascular effectiveness of human-based vs. exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes
E Longato, B Di Camillo, G Sparacino, L Tramontan, A Avogaro, ...
European Journal of Preventive Cardiology 28 (1), 22-29, 2021
82021
Exposure to dipeptidyl‐peptidase 4 inhibitors and the risk of pneumonia among people with type 2 diabetes: retrospective cohort study and meta‐analysis
ML Morieri, BM Bonora, E Longato, B Di Camilo, G Sparacino, ...
Diabetes, Obesity and Metabolism 22 (10), 1925-1934, 2020
82020
Improved long-term cardiovascular outcomes after intensive versus standard screening of diabetic complications: an observational study
ML Morieri, E Longato, M Mazzucato, B Di Camillo, A Cocchiglia, ...
Cardiovascular diabetology 18 (1), 1-9, 2019
72019
Expected accuracy of proximal and distal temperature estimated by wireless sensors, in relation to their number and position on the skin
E Longato, M Garrido, D Saccardo, C Montesinos Guevara, AR Mani, ...
PloS one 12 (6), e0180315, 2017
72017
Outcomes of patients with type 2 diabetes treated with SGLT-2 inhibitors versus DPP-4 inhibitors. An Italian real-world study in the context of other observational studies
E Longato, BM Bonora, B Di Camillo, G Sparacino, L Tramontan, ...
Diabetes Research and Clinical Practice 179, 109024, 2021
32021
Prediction of cardiovascular complications in diabetes from pharmacy administrative claims
E Longato, GP Fadini, G Sparacino, L Gubian, B Di Camillo
2020 IEEE 20th Mediterranean Electrotechnical Conference (MELECON), 315-320, 2020
32020
Importance of recalibrating models for type 2 diabetes onset prediction: application of the Diabetes Population Risk Tool on the health and retirement study
M Vettoretti, E Longato, B Di Camillo, A Facchinetti
2018 40th Annual International Conference of the IEEE Engineering in …, 2018
32018
Addressing practical issues of predictive models translation into everyday practice and public health management: a combined model to predict the risk of type 2 diabetes …
M Vettoretti, E Longato, A Zandonà, Y Li, JA Pagán, D Siscovick, ...
BMJ Open Diabetes Research and Care 8 (1), e001223, 2020
22020
Comparing the Predictive Power of Heart Failure Hospitalisation Risk Scores in the Diabetic Outpatient Clinic and Primary Care Settings
A Guazzo, A Battaggia, E Longato, B Franco-Novelletto, A Avogaro, ...
2021 IEEE International Conference on Bioinformatics and Biomedicine (BIBM …, 2021
12021
Ranking Physiological, Lifestyle and Environmental Risk Factors for Predicting Type 2 Diabetes Onset
A Zandona, M Vettoretti, E Longato, Y Li, K Madondo, J Pagan, ...
DIABETES TECHNOLOGY & THERAPEUTICS 21, A90-A90, 2019
12019
Il sistema al momento non può eseguire l'operazione. Riprova più tardi.
Articoli 1–20